Last updated: April 24, 2026

Application No. 19/305,728

Untitled Application

Unknown

Filed

1600

Examiner

CHONG, KIMBERLY

Art Unit

1636

Tech Center

Insitro, Inc.

Assignee

Insitro Inc.

OA Round

1 (Non-Final)

Interview Optional

— +12.6% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 1474 resolved cases, 2023–2026

Examiner Intelligence

CHONG, KIMBERLY View full profile →

Grants 72% — above average

Career Allow Rate

1067 granted / 1474 resolved

+12.4% vs TC avg

Moderate +13% lift

Without

With

+12.6%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

66 currently pending

Career history

1540

Total Applications

across all art units

Statute-Specific Performance

§101

3.9%

-36.1% vs TC avg

§103

26.8%

-13.2% vs TC avg

§102

20.5%

-19.5% vs TC avg

§112

29.5%

-10.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1474 resolved cases

Prosecution Timeline

1600

Application Filed

Jan 24, 2026

Non-Final Rejection

Apr 22, 2026

Examiner Interview Summary

Apr 22, 2026

Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

17/778,567

Patent 12595481

METHODS AND COMPOSITIONS FOR NEUROPROTECTION

2y 5m to grant Granted Apr 07, 2026

19/054,728

Patent 12590307

TRANSLATION ENHANCING NUCLEIC ACID COMPOUNDS: ASO COUPLED TRANSLATION – UPREGULATION 1 (ACT-UP1) AND USES THEREOF

2y 5m to grant Granted Mar 31, 2026

17/749,039

Patent 12571052

Immunomodulatory RNA

2y 5m to grant Granted Mar 10, 2026

19/052,052

Patent 12559750

Methods and Compositions for Treatment of Polycystic Kidney Disease

2y 5m to grant Granted Feb 24, 2026

17/898,947

Patent 12539309

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

2y 5m to grant Granted Feb 03, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

72%

Grant Probability

85%

With Interview (+12.6%)

2y 7m

Median Time to Grant

Low

PTA Risk

Based on 1474 resolved cases by this examiner. Grant probability derived from career allow rate.